Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-21-055311

EVP, Research & CSO sold 4,125 shares at an average $49.67 ($204,875)

  • EVP, Research & CSO acquired 4,125 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Virgin Herbert · EVP, Research & CSO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-09-07 Exercise or conversion : show line 1 in the form +4,125 $1.53 $6,311 103,825 D
2021-09-07 Sale : show line 2 in the form −1,375 $49.00 $67,375 102,450 D
2021-09-07 Sale : show line 3 in the form −2,750 $50.00 $137,500 99,700 D
Open-market sales · 4,125 sh · avg $49.67 · $204,875

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-09-07 Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) −4,125 263,255 D
Loading xslF345X03/doc4.xml…